Acinetobacter baumannii: Its Clinical Significance in Human and Veterinary Medicine

• Published in: Pathogens (Basel) Vol. 10; no. 2; p. 127
• Main Authors: Nocera, Francesca Paola, Attili, Anna-Rita, De Martino, Luisa
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 27.01.2021; MDPI
• Subjects: Acinetobacter baumannii; Adaptability; Antibiotics; Antimicrobial agents; bacteria; Bacterial infections; biofilm; Biofilms; Cattle; Clinical significance; Cloning; Coronaviruses; cross infection; Drug resistance; Health care; human medicine; humans; medicine; Mortality; multi-drug resistance; Multidrug resistance; multiple drug resistance; Nosocomial infection; Nosocomial infections; Opportunist infection; opportunistic pathogens; Pathogens; Pneumonia; Review; Severe acute respiratory syndrome coronavirus 2; therapeutics; Veterinary medicine; Veterinary services; Viral infections; Virulence; multi-drug resistance; Acinetobacter baumannii; veterinary medicine; biofilms; human medicine
• ISSN: 2076-0817; 2076-0817
• DOI: 10.3390/pathogens10020127

Acinetobacter baumannii is a Gram-negative, opportunistic pathogen, causing severe infections difficult to treat. The A. baumannii infection rate has increased year by year in human medicine and it is also considered as a major cause of nosocomial infections worldwide. This bacterium, also well known for its ability to form biofilms, has a strong environmental adaptability and the characteristics of multi-drug resistance. Indeed, strains showing fully resistant profiles represent a worrisome problem in clinical therapeutic treatment. Furthermore, A. baumannii-associated veterinary nosocomial infections has been reported in recent literature. Particularly, carbapenem-resistant A. baumannii can be considered an emerging opportunistic pathogen in human medicine as well as in veterinary medicine.